Caitong International Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Caitong International Asset Management's JAZZ Position: Q2 2026 in Review
Caitong International Asset Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 38 shares worth $9.16K. The stake represents ﹤0.01% of the portfolio and ranks #1176 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in JAZZ as recently as Q4 2025.
Caitong International Asset Management first reported a position in JAZZ in Q1 2025 and has held it in 5 quarters since. The position peaked at $80.3K in Q1 2025. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Caitong International Asset Management held 38 shares of Jazz Pharmaceuticals worth $9.16K as of Q2 2026.
- Jazz Pharmaceuticals was a new Caitong International Asset Management position in Q2 2026.
- Jazz Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1176 holding.
- Caitong International Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
- Caitong International Asset Management's Jazz Pharmaceuticals position peaked at $80.3K in Q1 2025.
- 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.